vs
LG化学（CHE）与Rithm Capital Corp.（RITM）财务数据对比。点击上方公司名可切换其他公司
Rithm Capital Corp.的季度营收约是LG化学的2.0倍（$828.2M vs $420.0M），LG化学净利率更高（15.8% vs 13.2%，领先2.6%），Rithm Capital Corp.同比增速更快（508.5% vs 3.1%），过去两年LG化学的营收复合增速更高（5.9% vs -17.9%）
LG化学是韩国最大的化工企业，总部位于韩国首尔，2021年按销售额统计为全球第九大化工企业。其前身为生产化妆品的乐喜化学工业株式会社，目前已全面转型为仅面向企业客户的B2B经营模式。
Rithm Capital Corp.是总部位于美国纽约的投资管理机构，核心业务聚焦房地产投资与另类资产投资，依托专业的投研团队和成熟的市场运营经验，为合作伙伴及投资者提供优质的资产配置解决方案与长期收益回报。
CHE vs RITM — 直观对比
营收规模更大
RITM
是对方的2.0倍
$420.0M
营收增速更快
RITM
高出505.4%
3.1%
净利率更高
CHE
高出2.6%
13.2%
两年增速更快
CHE
近两年复合增速
-17.9%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $420.0M | $828.2M |
| 净利润 | $66.3M | $109.5M |
| 毛利率 | — | — |
| 营业利润率 | 20.1% | 29.9% |
| 净利率 | 15.8% | 13.2% |
| 营收同比 | 3.1% | 508.5% |
| 净利润同比 | — | 27.7% |
| 每股收益（稀释后） | — | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CHERITM
| Q1 26 | $420.0M | $828.2M | ||
| Q4 25 | $639.3M | $1.5B | ||
| Q3 25 | $624.9M | $1.1B | ||
| Q2 25 | $618.8M | $1.2B | ||
| Q1 25 | $646.9M | $768.4M | ||
| Q4 24 | $411.0M | $2.1B | ||
| Q3 24 | $391.4M | $619.5M | ||
| Q2 24 | $374.6M | $1.2B |
净利润CHERITM
| Q1 26 | $66.3M | $109.5M | ||
| Q4 25 | $76.8M | $85.0M | ||
| Q3 25 | $64.2M | $221.5M | ||
| Q2 25 | $52.5M | $311.7M | ||
| Q1 25 | $71.8M | $78.8M | ||
| Q4 24 | $90.3M | $290.2M | ||
| Q3 24 | $75.8M | $121.7M | ||
| Q2 24 | $70.9M | $235.6M |
毛利率CHERITM
| Q1 26 | — | — | ||
| Q4 25 | 35.2% | — | ||
| Q3 25 | 31.5% | — | ||
| Q2 25 | 29.8% | — | ||
| Q1 25 | 33.5% | — | ||
| Q4 24 | 1.2% | — | ||
| Q3 24 | -1.2% | — | ||
| Q2 24 | -4.1% | — |
营业利润率CHERITM
| Q1 26 | 20.1% | 29.9% | ||
| Q4 25 | 15.7% | 13.8% | ||
| Q3 25 | 12.0% | 21.4% | ||
| Q2 25 | 11.0% | 25.2% | ||
| Q1 25 | 14.6% | 7.4% | ||
| Q4 24 | 27.7% | 23.8% | ||
| Q3 24 | 23.5% | 7.3% | ||
| Q2 24 | 23.5% | 23.6% |
净利率CHERITM
| Q1 26 | 15.8% | 13.2% | ||
| Q4 25 | 12.0% | 5.7% | ||
| Q3 25 | 10.3% | 20.0% | ||
| Q2 25 | 8.5% | 25.6% | ||
| Q1 25 | 11.1% | 10.3% | ||
| Q4 24 | 22.0% | 14.0% | ||
| Q3 24 | 19.4% | 19.7% | ||
| Q2 24 | 18.9% | 19.2% |
每股收益（稀释后）CHERITM
| Q1 26 | — | $0.12 | ||
| Q4 25 | $5.45 | $0.09 | ||
| Q3 25 | $4.46 | $0.35 | ||
| Q2 25 | $3.57 | $0.53 | ||
| Q1 25 | $4.86 | $0.07 | ||
| Q4 24 | $6.00 | $0.50 | ||
| Q3 24 | $5.00 | $0.20 | ||
| Q2 24 | $4.65 | $0.43 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $16.9M | — |
| 总债务越低越好 | $91.2M | — |
| 股东权益账面价值 | $848.0M | $9.1B |
| 总资产 | $1.5B | $53.4B |
| 负债/权益比越低杠杆越低 | 0.11× | — |
8季度趋势，按日历期对齐
现金及短期投资CHERITM
| Q1 26 | $16.9M | — | ||
| Q4 25 | $74.5M | $1.8B | ||
| Q3 25 | $129.8M | $1.6B | ||
| Q2 25 | $249.9M | $1.6B | ||
| Q1 25 | $173.9M | $1.5B | ||
| Q4 24 | $178.3M | $1.5B | ||
| Q3 24 | $238.5M | $1.6B | ||
| Q2 24 | $222.9M | $1.2B |
总债务CHERITM
| Q1 26 | $91.2M | — | ||
| Q4 25 | — | $35.4B | ||
| Q3 25 | — | $32.2B | ||
| Q2 25 | — | $31.2B | ||
| Q1 25 | — | $32.2B | ||
| Q4 24 | — | $32.6B | ||
| Q3 24 | — | $29.6B | ||
| Q2 24 | — | $30.1B |
股东权益CHERITM
| Q1 26 | $848.0M | $9.1B | ||
| Q4 25 | $979.4M | $8.4B | ||
| Q3 25 | $1.1B | $8.5B | ||
| Q2 25 | $1.2B | $7.9B | ||
| Q1 25 | $1.2B | $7.8B | ||
| Q4 24 | $1.1B | $7.8B | ||
| Q3 24 | $1.2B | $7.7B | ||
| Q2 24 | $1.2B | $7.3B |
总资产CHERITM
| Q1 26 | $1.5B | $53.4B | ||
| Q4 25 | $1.5B | $53.1B | ||
| Q3 25 | $1.6B | $47.2B | ||
| Q2 25 | $1.7B | $44.3B | ||
| Q1 25 | $1.7B | $45.3B | ||
| Q4 24 | $1.7B | $46.0B | ||
| Q3 24 | $1.8B | $42.3B | ||
| Q2 24 | $1.7B | $42.0B |
负债/权益比CHERITM
| Q1 26 | 0.11× | — | ||
| Q4 25 | — | 4.20× | ||
| Q3 25 | — | 3.79× | ||
| Q2 25 | — | 3.92× | ||
| Q1 25 | — | 4.14× | ||
| Q4 24 | — | 4.18× | ||
| Q3 24 | — | 3.87× | ||
| Q2 24 | — | 4.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $88.2M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 4.1% | — |
| 现金转化率经营现金流/净利润 | 1.33× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CHERITM
| Q1 26 | $88.2M | — | ||
| Q4 25 | $133.5M | $-114.6M | ||
| Q3 25 | $83.4M | $-2.0B | ||
| Q2 25 | $138.6M | $-557.1M | ||
| Q1 25 | $32.7M | $1.4B | ||
| Q4 24 | $164.9M | $-1.8B | ||
| Q3 24 | $90.5M | $768.1M | ||
| Q2 24 | $77.5M | $-55.7M |
自由现金流CHERITM
| Q1 26 | — | — | ||
| Q4 25 | $117.2M | — | ||
| Q3 25 | $66.0M | — | ||
| Q2 25 | $122.8M | — | ||
| Q1 25 | $19.5M | — | ||
| Q4 24 | $152.2M | — | ||
| Q3 24 | $77.0M | — | ||
| Q2 24 | $66.5M | — |
自由现金流率CHERITM
| Q1 26 | — | — | ||
| Q4 25 | 18.3% | — | ||
| Q3 25 | 10.6% | — | ||
| Q2 25 | 19.8% | — | ||
| Q1 25 | 3.0% | — | ||
| Q4 24 | 37.0% | — | ||
| Q3 24 | 19.7% | — | ||
| Q2 24 | 17.7% | — |
资本支出强度CHERITM
| Q1 26 | 4.1% | — | ||
| Q4 25 | 2.6% | — | ||
| Q3 25 | 2.8% | — | ||
| Q2 25 | 2.6% | — | ||
| Q1 25 | 2.1% | — | ||
| Q4 24 | 3.1% | — | ||
| Q3 24 | 3.5% | — | ||
| Q2 24 | 3.0% | — |
现金转化率CHERITM
| Q1 26 | 1.33× | — | ||
| Q4 25 | 1.74× | -1.35× | ||
| Q3 25 | 1.30× | -9.22× | ||
| Q2 25 | 2.64× | -1.79× | ||
| Q1 25 | 0.46× | 18.03× | ||
| Q4 24 | 1.83× | -6.04× | ||
| Q3 24 | 1.19× | 6.31× | ||
| Q2 24 | 1.09× | -0.24× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CHE
| Homecare | $371.1M | 88% |
| Inpatient | $35.9M | 9% |
| Other | $13.0M | 3% |
RITM
| Servicing revenue, net | $375.1M | 45% |
| Other | $234.9M | 28% |
| Gain on originated residential mortgage loans, held-for-sale, net | $195.0M | 24% |
| Other revenue | $23.3M | 3% |
